Financial reports
10-K
2023 FY
Annual report
19 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
10-K
2021 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
10 Mar 22
10-Q
2021 Q3
Quarterly report
1 Nov 21
Current reports
8-K
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
19 Mar 24
8-K
Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell
23 Jan 24
8-K
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
7 Nov 23
8-K
Other Events
6 Sep 23
8-K
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 23
8-K
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
8 May 23
8-K
Other Events
24 Apr 23
8-K
Departure of Directors or Certain Officers
3 Apr 23
8-K
Termination of a Material Definitive Agreement
29 Mar 23
Registration and prospectus
S-3
Shelf registration
28 Mar 23
S-8
Registration of securities for employees
28 Mar 23
S-8
Registration of securities for employees
5 May 22
424B5
Prospectus supplement for primary offering
2 Nov 21
S-8
Registration of securities for employees
29 Apr 21
424B5
Prospectus supplement for primary offering
12 Feb 21
424B5
Prospectus supplement for primary offering
11 Feb 21
S-8
Registration of securities for employees
30 Apr 20
424B5
Prospectus supplement for primary offering
20 Mar 20
S-3
Shelf registration
9 Mar 20
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
20 Apr 21
DEF 14A
Definitive proxy
20 Apr 21
DEFA14A
Additional proxy soliciting materials
15 Apr 20
DEF 14A
Definitive proxy
15 Apr 20
Other
EFFECT
Notice of effectiveness
9 May 23
CORRESP
Correspondence with SEC
4 May 23
UPLOAD
Letter from SEC
31 Mar 23
SEC STAFF
SEC staff action: Order
29 Mar 21
SEC STAFF
SEC staff action: Order
1 Mar 21
EFFECT
Notice of effectiveness
20 Mar 20
CORRESP
Correspondence with SEC
17 Mar 20
UPLOAD
Letter from SEC
12 Mar 20
UPLOAD
Letter from SEC
24 Aug 18
CORRESP
Correspondence with SEC
17 Aug 18